Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

The intra-assay reproducibility of thromboelastography in very low birth weight infants.

Ghirardello S, Raffaeli G, Scalambrino E, Chantarangkul V, Cavallaro G, Artoni A, Mosca F, Tripodi A.

Early Hum Dev. 2018 Oct 9;127:48-52. doi: 10.1016/j.earlhumdev.2018.10.004. [Epub ahead of print]

PMID:
30312859
2.

Advances in the Treatment of Hemophilia: Implications for Laboratory Testing.

Tripodi A, Chantarangkul V, Novembrino C, Peyvandi F.

Clin Chem. 2018 Oct 3. pii: clinchem.2017.284356. doi: 10.1373/clinchem.2017.284356. [Epub ahead of print] Review.

PMID:
30282700
3.

Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.

Tripodi A, Chantarangkul V, Legnani C, Testa S, Tosetto A.

J Thromb Haemost. 2018 Mar;16(3):565-570. doi: 10.1111/jth.13949. Epub 2018 Jan 29.

PMID:
29322630
4.

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A.

J Thromb Haemost. 2018 Jan;16(1):142-149. doi: 10.1111/jth.13879. Epub 2017 Dec 1.

PMID:
29065247
5.

Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).

Tripodi A, Chantarangkul V.

Methods Mol Biol. 2017;1646:177-183. doi: 10.1007/978-1-4939-7196-1_15.

PMID:
28804829
6.

Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.

Tripodi A, Chantarangkul V, Cini M, Devreese K, Dlott JS, Giacomello R, Gray E, Legnani C, Martinuzzo ME, Pradella P, Siegemund A, Subramanian S, Suchon P, Testa S.

J Thromb Haemost. 2017 Jun;15(6):1180-1190. doi: 10.1111/jth.13678. Epub 2017 Apr 18.

PMID:
28316135
7.

Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis.

Tripodi A, D'Ambrosio R, Padovan L, Tosetti G, Aghemo A, Primignani M, Chantarangkul V, Peyvandi F, Colombo M.

Liver Int. 2017 Sep;37(9):1295-1303. doi: 10.1111/liv.13374. Epub 2017 Feb 23.

PMID:
28129465
8.

Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

Tripodi A, Fracanzani AL, Chantarangkul V, Primignani M, Fargion S.

J Hepatol. 2017 Jan;66(1):248-250. doi: 10.1016/j.jhep.2016.09.025. Epub 2016 Oct 18. No abstract available.

PMID:
27769731
9.

Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists.

Tripodi A, Primignani M, Braham S, Chantarangkul V, Clerici M, Moia M, Peyvandi F.

Dig Liver Dis. 2016 Oct;48(10):1208-13. doi: 10.1016/j.dld.2016.06.027. Epub 2016 Jul 1.

PMID:
27470055
10.

Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.

Tripodi A, Ammollo CT, Semeraro F, Colucci M, Malchiodi E, Verrua E, Ferrante E, Arnaldi G, Trementino L, Padovan L, Chantarangkul V, Peyvandi F, Mantovani G.

Endocrine. 2017 May;56(2):298-307. doi: 10.1007/s12020-016-1027-1. Epub 2016 Jul 22.

PMID:
27448294
11.

Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents.

Mancuso ME, Chantarangkul V, Clerici M, Fasulo MR, Padovan L, Scalambrino E, Peyvandi F, Tripodi A, Santagostino E.

Haemophilia. 2016 Jul;22(4):e292-300. doi: 10.1111/hae.12939. Epub 2016 May 16.

PMID:
27197961
12.

The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A.

Mancuso ME, Chantarangkul V, Clerici M, Fasulo MR, Padovan L, Scalambrino E, Peyvandi F, Tripodi A, Santagostino E.

Haemophilia. 2016 Jul;22(4):e286-91. doi: 10.1111/hae.12927. Epub 2016 May 11.

PMID:
27166132
13.

Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.

La Mura V, Tripodi A, Tosetti G, Cavallaro F, Chantarangkul V, Colombo M, Primignani M.

Liver Int. 2016 Sep;36(9):1322-30. doi: 10.1111/liv.13087. Epub 2016 Mar 31.

PMID:
26854258
14.

Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban.

Tripodi A, Martinelli I, Chantarangkul V, Clerici M, Artoni A, Passamonti S, Peyvandi F.

Int J Hematol. 2016 Feb;103(2):165-72. doi: 10.1007/s12185-015-1898-6. Epub 2015 Nov 19.

PMID:
26586461
15.

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: comment.

Tripodi A, Chantarangkul V, Primignani M.

J Thromb Haemost. 2015 Oct;13(10):1941-3. doi: 10.1111/jth.13056. Epub 2015 Aug 27. No abstract available.

16.

Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe haemophiliacs: comment.

Tripodi A, Chantarangkul V, Santagostino E.

J Thromb Haemost. 2015 Jan;13(1):163-4. doi: 10.1111/jth.12769. Epub 2014 Nov 17. No abstract available.

17.

How the direct oral anticoagulant apixaban affects hemostatic parameters. Results of a multicenter multiplatform study.

Tripodi A, Padovan L, Testa S, Legnani C, Chantarangkul V, Scalambrino E, Ludovici S, Bassi L, Peyvandi F.

Clin Chem Lab Med. 2015 Feb;53(2):265-73. doi: 10.1515/cclm-2014-0531.

PMID:
25153405
18.

Statins decrease thrombin generation in patients with hypercholesterolemia.

Tripodi A, Pellegatta F, Chantarangkul V, Grigore L, Garlaschelli K, Baragetti A, Lemma L, Catapano A.

Eur J Intern Med. 2014 Jun;25(5):449-51. doi: 10.1016/j.ejim.2014.03.016. Epub 2014 Apr 29. Erratum in: Eur J Intern Med. 2015 Jul;26(6):460.

PMID:
24784951
19.

Thrombin generation in patients with idiopathic sudden sensorineural hearing loss.

Tripodi A, Capaccio P, Pignataro L, Chantarangkul V, Menegatti M, Bamonti F, Clerici M, De Giuseppe R, Peyvandi F.

Thromb Res. 2014 Jun;133(6):1130-4. doi: 10.1016/j.thromres.2014.03.031. Epub 2014 Mar 21.

PMID:
24690481
20.

Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

Tripodi A, Fracanzani AL, Primignani M, Chantarangkul V, Clerici M, Mannucci PM, Peyvandi F, Bertelli C, Valenti L, Fargion S.

J Hepatol. 2014 Jul;61(1):148-54. doi: 10.1016/j.jhep.2014.03.013. Epub 2014 Mar 18.

PMID:
24657400
21.

Global coagulation in myeloproliferative neoplasms.

Tripodi A, Chantarangkul V, Gianniello F, Clerici M, Lemma L, Padovan L, Gatti L, Mannucci PM, Peyvandi F.

Ann Hematol. 2013 Dec;92(12):1633-9. doi: 10.1007/s00277-013-1834-x. Epub 2013 Jul 3.

PMID:
23820940
22.

Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant.

Chantarangkul V, Biguzzi E, Asti D, Palmucci C, Tripodi A.

Thromb Haemost. 2013 Jul;110(1):46-52. doi: 10.1160/TH12-11-0850. Epub 2013 Apr 25.

PMID:
23615569
23.

Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.

Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM.

J Hepatol. 2013 Aug;59(2):265-70. doi: 10.1016/j.jhep.2013.03.036. Epub 2013 Apr 11.

PMID:
23583273
24.

Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

Pregnolato F, Chighizola CB, Encabo S, Shums Z, Norman GL, Tripodi A, Chantarangkul V, Bertero T, De Micheli V, Borghi MO, Meroni PL.

Immunol Res. 2013 Jul;56(2-3):432-8. doi: 10.1007/s12026-013-8421-z.

PMID:
23572433
25.

Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.

Tripodi A, Primignani M, Chantarangkul V, Lemma L, Jovani M, Rebulla P, Mannucci PM.

Liver Int. 2013 Mar;33(3):362-7. doi: 10.1111/liv.12038. Epub 2012 Dec 11.

PMID:
23231699
26.

Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents.

Tripodi A, Chantarangkul V, Mancuso ME, Lemma L, Clerici M, Santagostino E.

J Thromb Haemost. 2012 Apr;10(4):716-9. No abstract available.

PMID:
22934293
27.

Discrepancy of the international normalized ratio observed in the external quality assessment survey: a cause for concern.

Tripodi A, Chantarangkul V, Legnani C, Fronton R, Testa S.

J Thromb Haemost. 2012 Apr;10(4):714-6. No abstract available.

PMID:
22934292
28.

Standardization of lupus anticoagulant. The Lupus Anticoagulant Sensitivity Index (LASI).

Tripodi A, Chantarangkul V, Pengo V.

Lupus. 2012 Jun;21(7):715-7. doi: 10.1177/0961203312438114.

PMID:
22635210
29.

Residual platelets are the main determinants of microparticles count in frozen-thawed plasma.

Artoni A, Merati G, Padovan L, Scalambrino E, Chantarangkul V, Tripodi A.

Thromb Res. 2012 Sep;130(3):561-2. doi: 10.1016/j.thromres.2012.04.012. Epub 2012 May 17. No abstract available.

PMID:
22608211
30.

Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability.

Tripodi A, Chantarangkul V, Clerici M, Palmucci C, Bison E, Banzato A, Biguzzi E, Pengo V.

Thromb Res. 2011 Jun;127(6):589-94. doi: 10.1016/j.thromres.2011.01.015. Epub 2011 Feb 26.

PMID:
21356545
31.

Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma.

Tripodi A, Chantarangkul V, Primignani M, Clerici M, Dell'era A, Aghemo A, Mannucci PM.

Intern Emerg Med. 2012 Apr;7(2):139-44. doi: 10.1007/s11739-011-0528-4. Epub 2011 Feb 5.

PMID:
21298360
32.

More on: enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.

Tripodi A, Primignani M, Chantarangkul V, Mannucci PM.

J Thromb Haemost. 2011 Mar;9(3):612-3; author reply 613-14. doi: 10.1111/j.1538-7836.2010.04127.x. No abstract available.

33.

The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study.

Tripodi A, Chantarangkul V, Guinet C, Samama MM.

J Thromb Haemost. 2011 Jan;9(1):226-8. doi: 10.1111/j.1538-7836.2010.04106.x. No abstract available.

34.

Pro-coagulant imbalance in patients with chronic liver disease.

Tripodi A, Primignani M, Chantarangkul V, Mannucci PM.

J Hepatol. 2010 Sep;53(3):586-7. doi: 10.1016/j.jhep.2010.03.031. Epub 2010 Jun 1. No abstract available.

35.

Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay.

Tripodi A, Branchi A, Chantarangkul V, Clerici M, Merati G, Artoni A, Mannucci PM.

J Thromb Thrombolysis. 2011 Feb;31(2):165-72. doi: 10.1007/s11239-010-0506-0.

PMID:
20640482
36.

International collaborative study for the calibration of a proposed international standard for thromboplastin, human, plain.

Tripodi A, Chantarangkul V, Van Den Besselaar AM, Witteveen E, Hubbard AR; subcommittee on Control of Anticoagulation of the SSC of the ISTH.

J Thromb Haemost. 2010 Sep;8(9):2066-8. doi: 10.1111/j.1538-7836.2010.03980.x. No abstract available.

37.

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method.

Tripodi A, Primignani M, Lemma L, Chantarangkul V, Dell'Era A, Iannuzzi F, Aghemo A, Mannucci PM.

Hepatology. 2010 Jul;52(1):249-55. doi: 10.1002/hep.23653.

PMID:
20578143
38.

More on: new antithrombotics: a need for laboratory monitoring. For or against.

Tripodi A, Chantarangkul V, Moia M.

J Thromb Haemost. 2010 Sep;8(9):2087-8. doi: 10.1111/j.1538-7836.2010.03947.x. No abstract available.

39.

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.

Tripodi A, Legnani C, Lemma L, Cosmi B, Palareti G, Chantarangkul V, Mannucci PM.

J Thromb Thrombolysis. 2010 Aug;30(2):215-9. doi: 10.1007/s11239-010-0479-z.

PMID:
20419336
40.

Thromboplastin standards.

van den Besselaar AM, Chantarangkul V, Tripodi A.

Biologicals. 2010 Jul;38(4):430-6. doi: 10.1016/j.biologicals.2010.02.012. Epub 2010 Mar 24. Review.

PMID:
20338779
41.

Effect of prothrombin time outlier exclusion rules on ISI calibration in multicentre studies.

van den Besselaar AM, Chantarangkul V, Tripodi A.

Thromb Res. 2010 Jun;125(6):523-8. doi: 10.1016/j.thromres.2010.01.006. Epub 2010 Feb 1.

PMID:
20117825
42.

Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.

Santagostino E, Mancuso ME, Tripodi A, Chantarangkul V, Clerici M, Garagiola I, Mannucci PM.

J Thromb Haemost. 2010 Apr;8(4):737-43. doi: 10.1111/j.1538-7836.2010.03767.x. Epub 2009 Jan 21.

43.

Increased thrombin generation in inflammatory bowel diseases.

Saibeni S, Saladino V, Chantarangkul V, Villa F, Bruno S, Vecchi M, de Franchis R, Sei C, Tripodi A.

Thromb Res. 2010 Mar;125(3):278-82. doi: 10.1016/j.thromres.2009.10.012. Epub 2009 Nov 14.

PMID:
19914688
44.

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM.

Gastroenterology. 2009 Dec;137(6):2105-11. doi: 10.1053/j.gastro.2009.08.045. Epub 2009 Aug 23.

PMID:
19706293
45.

Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.

Tripodi A, Chantarangkul V, Mannucci PM.

Br J Haematol. 2009 Oct;147(1):77-82. doi: 10.1111/j.1365-2141.2009.07833.x. Epub 2009 Jul 30.

PMID:
19659548
46.

Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma.

Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, Mannucci PM.

Haematologica. 2009 Nov;94(11):1520-7. doi: 10.3324/haematol.2009.010546. Epub 2009 Jul 31.

47.

Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.

Tripodi A, Chantarangkul V, Primignani M, Dell'Era A, Clerici M, Iannuzzi F, Aghemo A, Cazzaniga M, Salerno F, Mannucci PM.

J Hepatol. 2009 Aug;51(2):288-95. doi: 10.1016/j.jhep.2009.04.014. Epub 2009 May 20.

PMID:
19501423
48.

More on: high thrombin generation and the risk of recurrent venous thromboembolism.

Tripodi A, Legnani C, Palareti G, Chantarangkul V, Mannucci PM.

J Thromb Haemost. 2009 May;7(5):906-7. doi: 10.1111/j.1538-7836.2009.03338.x. Epub 2009 Mar 6. No abstract available.

49.

The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters.

Tripodi A, Primignani M, Chantarangkul V, Viscardi Y, Dell'Era A, Fabris FM, Mannucci PM.

Thromb Res. 2009 May;124(1):132-6. doi: 10.1016/j.thromres.2008.11.008. Epub 2009 Jan 9.

PMID:
19135704
50.

Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).

Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani MT, Chung DW, Ferrari S, Fujimura Y, Karimi M, Kokame K, Kremer Hovinga JA, Lämmle B, de Meyer SF, Plaimauer B, Vanhoorelbeke K, Varadi K, Mannucci PM.

J Thromb Haemost. 2008 Sep;6(9):1534-41. doi: 10.1111/j.1538-7836.2008.03099.x. Epub 2008 Jul 26.

Supplemental Content

Loading ...
Support Center